The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia
The clinical effectiveness of moxisylyte hydrochloride (Moxyl, Fuji Rebio), a selective alpha 1-adrenoceptor blocking agent, was investigated in patients with symptomatic benign prostatic hyperplasia. Moxisylyte hydrochloride was administered at the dose of 90 mg per day orally for four weeks. Resid...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 35(1989), 3 vom: 16. März, Seite 541-9 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1989
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Adrenergic alpha-Antagonists Moxisylyte PW8QYA7KI0 |